General Info
Location: 158-160 North Gower Street
Country: United Kingdom of Great Britain and Northern Ireland
Industries: Life Sciences, new drug discovery, med tech, enabling technologies, vaccines
Investment Regions: EU, NA
Investment Stages: seed, series-a
Website: http://www.adventls.com/
vc
EU, NA
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: very-active
AI Reasoning: I found a press release on Advent Life Sciences’ website showing Glycomine announced a $115M Series C financing on April 16, 2025 with Advent Life Sciences listed as an investor. The time between that investment (April 16, 2025) and the evaluation date is less than 3 months; therefore the correct tag is very-active. The startup invested was Glycomine.
Here are the thresholds established for the different statuses:
Not Active – No known investments in the last 12 months.
Low Activity – Only known investments between the last 12 and 6 months.
Active – Known investments between the last 6 and 3 months.
Very Active – Known investments in the last 3 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
Alain …
Partner
Chris …
Analyst
Don …
Venture Partner
Ian …
Operating Partner
John …
Operating Partner
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Advent Life Sciences LLP
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI